CP-197 Ivermectin enema elaboration for the treatment of strongyloides hyperinfection
Background Strongiloides stercolaris can produce a life threatening illness in inmunosuppressed hosts. Treatment options are limited to oral formulations and there are few data on alternative therapies.PurposeTo describe the preparation of ivermectin enema and evaluate its effectiveness in the treat...
Gespeichert in:
Veröffentlicht in: | European journal of hospital pharmacy. Science and practice 2016-03, Vol.23 (Suppl 1), p.A87-A87 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | A87 |
---|---|
container_issue | Suppl 1 |
container_start_page | A87 |
container_title | European journal of hospital pharmacy. Science and practice |
container_volume | 23 |
creator | Garcia, C Mondelo Queiruga, M Garcia Cortizas, B Feal Herranz, MI Martin |
description | Background Strongiloides stercolaris can produce a life threatening illness in inmunosuppressed hosts. Treatment options are limited to oral formulations and there are few data on alternative therapies.PurposeTo describe the preparation of ivermectin enema and evaluate its effectiveness in the treatment of Strongyloides hyperinfection.Material and methodsBibliographic search in Medline (keywords: ivermectin, rectal, Strongyloides) to determine the main characteristics of ivermectin enema: concentration, composition, elaboration method, packaging material, stability and storage conditions. Review of the electronic medical records and follow-up of the patient during hospitalisation.ResultsA 57-year-old man of Brazilian origin, presnted to the emergency department with nauseas, vomiting and dizziness. Imaging tests show lesions in his brain, and consequently he underwent neurosurgery. After a month the patient has haemodynamic instability and was transferred to intensive care where he was diagnosed with Strongyloides hyperinfection by wet prep of bronchial suction on 18 August 2014. Treatment was initiated with ivermectin 200 µg/kg/24 h by nasogastric tube. On 19 August, Strongyloides was isolated in faecal cultures and ivermectin enema 200 µg/kg/24 h was added to the treatment on 22 August. Since the beginning of the treatment, several microbiological controls have been done: on 25 August Strongyloides larvas were observed in bronchial suction and on 27 August in faecal cultures but with no movement capacity in both samples. On 3 and 5 September, bronchial suction and faecal cultures were done and the results were negative. Treatment by nasogastric tube and rectal ivermectin finished on 5 September.Elaboration of ivermectin enema was required by the pharmacy service because it does not exist as a commercial presentation appropriate for rectal administration. A standardised protocol was made.Elaboration process: crush ivermectin 12 mg in a mortar until it is a fine powder. Wet the powder with a small quantity of carboxymethylcellulose 1.5% until a homogeneous mixture is achieved. Add small porportions of carboxymethylcellulose up to 30 ml. Concerning stability, the enema has to be used immediately.ConclusionA protocol for the elaboration of Ivermectin enema was stablished. Treatment with rectal ivermectin added to ivermectin oral administration is an effective therapeutic option for the treatment of Strongyloides hyperinfection.References and/or Acknowledgeme |
doi_str_mv | 10.1136/ejhpharm-2016-000875.197 |
format | Article |
fullrecord | <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2552749060</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2552749060</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1000-910ecf4d2e478253acbf193eacfb1e1c93d375bd261a72707ff247283a1dd6d3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EElXpP1hineJX7HiJKh6VKsGiEkvLScYkVWMHx0XKjg0_ypeQqsCS1czi3DujgxCmZEkplzewa_rGxi5jhMqMEFKofEm1OkMzRoTKtJbi_G_P5SVaDENbkpzzQguuZ-hl9ZxNga-Pz_U7xA6q1HoMHjqLYW_LEG1qg8cuRJwawCmCTR34hIPDQ4rBv4770NYw4GbsIbbeHSuCv0IXzu4HWPzMOdre321Xj9nm6WG9ut1kJZ3ezTQlUDlRMxCqYDm3Vemo5mArV1KgleY1V3lZM0mtYooo55hQrOCW1rWs-Rxdn2r7GN4OMCSzC4fop4uG5TlTQhNJ_qOoKoSQmisxUfxEld3O9LHtbBwNJeZo2vyaNkfT5mTaTOL4N1n0dGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1784469374</pqid></control><display><type>article</type><title>CP-197 Ivermectin enema elaboration for the treatment of strongyloides hyperinfection</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Garcia, C Mondelo ; Queiruga, M Garcia ; Cortizas, B Feal ; Herranz, MI Martin</creator><creatorcontrib>Garcia, C Mondelo ; Queiruga, M Garcia ; Cortizas, B Feal ; Herranz, MI Martin</creatorcontrib><description>Background Strongiloides stercolaris can produce a life threatening illness in inmunosuppressed hosts. Treatment options are limited to oral formulations and there are few data on alternative therapies.PurposeTo describe the preparation of ivermectin enema and evaluate its effectiveness in the treatment of Strongyloides hyperinfection.Material and methodsBibliographic search in Medline (keywords: ivermectin, rectal, Strongyloides) to determine the main characteristics of ivermectin enema: concentration, composition, elaboration method, packaging material, stability and storage conditions. Review of the electronic medical records and follow-up of the patient during hospitalisation.ResultsA 57-year-old man of Brazilian origin, presnted to the emergency department with nauseas, vomiting and dizziness. Imaging tests show lesions in his brain, and consequently he underwent neurosurgery. After a month the patient has haemodynamic instability and was transferred to intensive care where he was diagnosed with Strongyloides hyperinfection by wet prep of bronchial suction on 18 August 2014. Treatment was initiated with ivermectin 200 µg/kg/24 h by nasogastric tube. On 19 August, Strongyloides was isolated in faecal cultures and ivermectin enema 200 µg/kg/24 h was added to the treatment on 22 August. Since the beginning of the treatment, several microbiological controls have been done: on 25 August Strongyloides larvas were observed in bronchial suction and on 27 August in faecal cultures but with no movement capacity in both samples. On 3 and 5 September, bronchial suction and faecal cultures were done and the results were negative. Treatment by nasogastric tube and rectal ivermectin finished on 5 September.Elaboration of ivermectin enema was required by the pharmacy service because it does not exist as a commercial presentation appropriate for rectal administration. A standardised protocol was made.Elaboration process: crush ivermectin 12 mg in a mortar until it is a fine powder. Wet the powder with a small quantity of carboxymethylcellulose 1.5% until a homogeneous mixture is achieved. Add small porportions of carboxymethylcellulose up to 30 ml. Concerning stability, the enema has to be used immediately.ConclusionA protocol for the elaboration of Ivermectin enema was stablished. Treatment with rectal ivermectin added to ivermectin oral administration is an effective therapeutic option for the treatment of Strongyloides hyperinfection.References and/or AcknowledgementsTarr PE, Miele PS, Peregoid KS, et al. Case report: Rectal administration of ivermectin. Am J Trop Med Hyg 2003;68:453-5No conflict of interest.</description><identifier>ISSN: 2047-9956</identifier><identifier>EISSN: 2047-9964</identifier><identifier>DOI: 10.1136/ejhpharm-2016-000875.197</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Suctioning</subject><ispartof>European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A87-A87</ispartof><rights>2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>2016 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Garcia, C Mondelo</creatorcontrib><creatorcontrib>Queiruga, M Garcia</creatorcontrib><creatorcontrib>Cortizas, B Feal</creatorcontrib><creatorcontrib>Herranz, MI Martin</creatorcontrib><title>CP-197 Ivermectin enema elaboration for the treatment of strongyloides hyperinfection</title><title>European journal of hospital pharmacy. Science and practice</title><description>Background Strongiloides stercolaris can produce a life threatening illness in inmunosuppressed hosts. Treatment options are limited to oral formulations and there are few data on alternative therapies.PurposeTo describe the preparation of ivermectin enema and evaluate its effectiveness in the treatment of Strongyloides hyperinfection.Material and methodsBibliographic search in Medline (keywords: ivermectin, rectal, Strongyloides) to determine the main characteristics of ivermectin enema: concentration, composition, elaboration method, packaging material, stability and storage conditions. Review of the electronic medical records and follow-up of the patient during hospitalisation.ResultsA 57-year-old man of Brazilian origin, presnted to the emergency department with nauseas, vomiting and dizziness. Imaging tests show lesions in his brain, and consequently he underwent neurosurgery. After a month the patient has haemodynamic instability and was transferred to intensive care where he was diagnosed with Strongyloides hyperinfection by wet prep of bronchial suction on 18 August 2014. Treatment was initiated with ivermectin 200 µg/kg/24 h by nasogastric tube. On 19 August, Strongyloides was isolated in faecal cultures and ivermectin enema 200 µg/kg/24 h was added to the treatment on 22 August. Since the beginning of the treatment, several microbiological controls have been done: on 25 August Strongyloides larvas were observed in bronchial suction and on 27 August in faecal cultures but with no movement capacity in both samples. On 3 and 5 September, bronchial suction and faecal cultures were done and the results were negative. Treatment by nasogastric tube and rectal ivermectin finished on 5 September.Elaboration of ivermectin enema was required by the pharmacy service because it does not exist as a commercial presentation appropriate for rectal administration. A standardised protocol was made.Elaboration process: crush ivermectin 12 mg in a mortar until it is a fine powder. Wet the powder with a small quantity of carboxymethylcellulose 1.5% until a homogeneous mixture is achieved. Add small porportions of carboxymethylcellulose up to 30 ml. Concerning stability, the enema has to be used immediately.ConclusionA protocol for the elaboration of Ivermectin enema was stablished. Treatment with rectal ivermectin added to ivermectin oral administration is an effective therapeutic option for the treatment of Strongyloides hyperinfection.References and/or AcknowledgementsTarr PE, Miele PS, Peregoid KS, et al. Case report: Rectal administration of ivermectin. Am J Trop Med Hyg 2003;68:453-5No conflict of interest.</description><subject>Suctioning</subject><issn>2047-9956</issn><issn>2047-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kMtOwzAQRS0EElXpP1hineJX7HiJKh6VKsGiEkvLScYkVWMHx0XKjg0_ypeQqsCS1czi3DujgxCmZEkplzewa_rGxi5jhMqMEFKofEm1OkMzRoTKtJbi_G_P5SVaDENbkpzzQguuZ-hl9ZxNga-Pz_U7xA6q1HoMHjqLYW_LEG1qg8cuRJwawCmCTR34hIPDQ4rBv4770NYw4GbsIbbeHSuCv0IXzu4HWPzMOdre321Xj9nm6WG9ut1kJZ3ezTQlUDlRMxCqYDm3Vemo5mArV1KgleY1V3lZM0mtYooo55hQrOCW1rWs-Rxdn2r7GN4OMCSzC4fop4uG5TlTQhNJ_qOoKoSQmisxUfxEld3O9LHtbBwNJeZo2vyaNkfT5mTaTOL4N1n0dGw</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Garcia, C Mondelo</creator><creator>Queiruga, M Garcia</creator><creator>Cortizas, B Feal</creator><creator>Herranz, MI Martin</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201603</creationdate><title>CP-197 Ivermectin enema elaboration for the treatment of strongyloides hyperinfection</title><author>Garcia, C Mondelo ; Queiruga, M Garcia ; Cortizas, B Feal ; Herranz, MI Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1000-910ecf4d2e478253acbf193eacfb1e1c93d375bd261a72707ff247283a1dd6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Suctioning</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garcia, C Mondelo</creatorcontrib><creatorcontrib>Queiruga, M Garcia</creatorcontrib><creatorcontrib>Cortizas, B Feal</creatorcontrib><creatorcontrib>Herranz, MI Martin</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>European journal of hospital pharmacy. Science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garcia, C Mondelo</au><au>Queiruga, M Garcia</au><au>Cortizas, B Feal</au><au>Herranz, MI Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CP-197 Ivermectin enema elaboration for the treatment of strongyloides hyperinfection</atitle><jtitle>European journal of hospital pharmacy. Science and practice</jtitle><date>2016-03</date><risdate>2016</risdate><volume>23</volume><issue>Suppl 1</issue><spage>A87</spage><epage>A87</epage><pages>A87-A87</pages><issn>2047-9956</issn><eissn>2047-9964</eissn><abstract>Background Strongiloides stercolaris can produce a life threatening illness in inmunosuppressed hosts. Treatment options are limited to oral formulations and there are few data on alternative therapies.PurposeTo describe the preparation of ivermectin enema and evaluate its effectiveness in the treatment of Strongyloides hyperinfection.Material and methodsBibliographic search in Medline (keywords: ivermectin, rectal, Strongyloides) to determine the main characteristics of ivermectin enema: concentration, composition, elaboration method, packaging material, stability and storage conditions. Review of the electronic medical records and follow-up of the patient during hospitalisation.ResultsA 57-year-old man of Brazilian origin, presnted to the emergency department with nauseas, vomiting and dizziness. Imaging tests show lesions in his brain, and consequently he underwent neurosurgery. After a month the patient has haemodynamic instability and was transferred to intensive care where he was diagnosed with Strongyloides hyperinfection by wet prep of bronchial suction on 18 August 2014. Treatment was initiated with ivermectin 200 µg/kg/24 h by nasogastric tube. On 19 August, Strongyloides was isolated in faecal cultures and ivermectin enema 200 µg/kg/24 h was added to the treatment on 22 August. Since the beginning of the treatment, several microbiological controls have been done: on 25 August Strongyloides larvas were observed in bronchial suction and on 27 August in faecal cultures but with no movement capacity in both samples. On 3 and 5 September, bronchial suction and faecal cultures were done and the results were negative. Treatment by nasogastric tube and rectal ivermectin finished on 5 September.Elaboration of ivermectin enema was required by the pharmacy service because it does not exist as a commercial presentation appropriate for rectal administration. A standardised protocol was made.Elaboration process: crush ivermectin 12 mg in a mortar until it is a fine powder. Wet the powder with a small quantity of carboxymethylcellulose 1.5% until a homogeneous mixture is achieved. Add small porportions of carboxymethylcellulose up to 30 ml. Concerning stability, the enema has to be used immediately.ConclusionA protocol for the elaboration of Ivermectin enema was stablished. Treatment with rectal ivermectin added to ivermectin oral administration is an effective therapeutic option for the treatment of Strongyloides hyperinfection.References and/or AcknowledgementsTarr PE, Miele PS, Peregoid KS, et al. Case report: Rectal administration of ivermectin. Am J Trop Med Hyg 2003;68:453-5No conflict of interest.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/ejhpharm-2016-000875.197</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2047-9956 |
ispartof | European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A87-A87 |
issn | 2047-9956 2047-9964 |
language | eng |
recordid | cdi_proquest_journals_2552749060 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Suctioning |
title | CP-197 Ivermectin enema elaboration for the treatment of strongyloides hyperinfection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T11%3A52%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CP-197%E2%80%85Ivermectin%20enema%20elaboration%20for%20the%20treatment%20of%20strongyloides%20hyperinfection&rft.jtitle=European%20journal%20of%20hospital%20pharmacy.%20Science%20and%20practice&rft.au=Garcia,%20C%20Mondelo&rft.date=2016-03&rft.volume=23&rft.issue=Suppl%201&rft.spage=A87&rft.epage=A87&rft.pages=A87-A87&rft.issn=2047-9956&rft.eissn=2047-9964&rft_id=info:doi/10.1136/ejhpharm-2016-000875.197&rft_dat=%3Cproquest_bmj_p%3E2552749060%3C/proquest_bmj_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1784469374&rft_id=info:pmid/&rfr_iscdi=true |